Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diffuse toxic goiter].

I I Dedov, G A Mel'nichenko, G F Aleksandrova

    Klinicheskaia Meditsina
    |May 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Diffuse toxic goiter, an autoimmune thyroid disease, often requires careful surgical preparation, especially when combined with endocrine ophthalmopathy. Elderly patients may present with unusual symptoms, necessitating lifelong monitoring due to the condition's relapsing nature.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Menopausal hormone therapy in patients with cardiovascular and metabolic diseases: an interdisciplinary Delphi consensus among Russian gynecologists, cardiologists, endocrinologists, gerontologists and geriatricians, phlebologists, and clinical pharmacologists].

    Terapevticheskii arkhiv·2026
    Same author

    [Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG].

    Problemy endokrinologii·2026
    Same author

    [Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP, RSMSI, RAGG].

    Kardiologiia·2025
    Same author

    [Contemporary capabilities of CT texture analysis in the diagnosis of pheochromocytoma: associations with clinical, laboratory, and pathomorphological findings].

    Terapevticheskii arkhiv·2025
    Same author

    [The single centre experience - from Recklinghausen to the present].

    Terapevticheskii arkhiv·2025
    Same author

    Clinical metabolomics: current state and prospects in Russia.

    Biomeditsinskaia khimiia·2024

    Area of Science:

    • Endocrinology
    • Immunology
    • Geriatrics

    Context:

    • Diffuse toxic goiter (DTG) is a prevalent organ-specific autoimmune thyroid disorder.
    • DTG frequently co-occurs with endocrine ophthalmopathy, complicating patient management.
    • Elderly individuals often exhibit atypical DTG presentations, including subtle gland enlargement, depression, cardiac issues, and treatment resistance.

    Purpose:

    • To highlight the complexities in managing diffuse toxic goiter, particularly in elderly patients.
    • To emphasize the importance of thorough pre-operative assessment when DTG is associated with endocrine ophthalmopathy.
    • To underscore the need for long-term follow-up due to the chronic and relapsing nature of DTG.

    Summary:

    • Diffuse toxic goiter is a common autoimmune thyroid condition.

    Related Experiment Videos

  • Atypical presentations are common in the elderly, manifesting as mild goiter, depression, cardiac issues, or thyrotoxicosis resistance.
  • Co-occurrence with endocrine ophthalmopathy mandates meticulous surgical preparation and lifelong monitoring for relapses.

    • Impact:

    • Improved diagnostic accuracy for atypical elderly DTG cases.
    • Enhanced pre-surgical protocols for patients with co-existing endocrine ophthalmopathy.
    • Optimized long-term management strategies for diffuse toxic goiter, reducing relapse rates.